Opportunities Preloader

Please Wait.....

Report

Molecular Diagnostics: Technologies and Global Markets

Market Research Report I 2022-04-14 I 204 Pages I BCC Research

Description

Report Scope:

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The goal of all DNA-based diagnostic assays is similar, but several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents and factors affecting the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also examined.

Key molecular diagnostic technologies and products are analyzed to determine present and future market status, and growth is forecast from 2021 to 2026. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces are also provided.

Report Includes:

- 60 tables
- An overview of the global market and technologies for molecular diagnostics
- Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region
- Information about food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of novel therapeutic products and their approvals
- Discussion on related issues, government regulations, and reimbursement through insurance, patient confidentiality and other legal ramifications
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players, including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc.

Executive Summary

Summary:

The global market for molecular diagnosticswas valued at REDACTED in 2020. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED by 2026.

Medical device companies, both industry giants and startups, are significantly investing in research and development (R&D) to develop innovative diagnosticproducts that can manage a host ofmedical conditions, including obesity, sleep apnea, diabetes,chronicobstructive pulmonary disease (COPD), asthmaand cardiac diseases, aswell as disability rehabilitation and the monitoring of progressive nervous systemdisorders, such as Parkinson's disease.

The increasing prevalence of diseases requiring round-the-clockmonitoring is an important driverof the market, and it is expected to significantly contribute to the industry's double-digit growth, especially considering the increase in the global geriatric population. Technological advancements are also promoting the adoption of many diagnostic products.

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
What's New in This Update?
Scope of Report
Methodology
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Introduction to Genomic Diagnostics
Expression Profiling and Disease
Expression Profiling and Infectious Disease
DNA Sequencing for Genotyping and Diagnosis
Clinical Pharmacology
Mutation Detection and Genotyping for Specific Genes
Identification of New Disease Genes
Chapter 4 Impact of the COVID-19 Pandemic
Introduction
Impact of COVID-19 on Market
Changes in Consumption Trends for Health-Related Products
Chapter 5 Market Dynamics
Market Drivers
High Incidences of Infectious Diseases
Increasing Incidences of Chronic Disease
Increasing Research and Development Budget
Increasing Healthcare Expenditures
Restraints and Challenges
Stringent Regulatory Framework
High R&D and Marketing Costs
Opportunities
Point-of Care Tests that Minimize Dependency on Lab Testing
Discovery of New Biomarkers and Advances in Molecular Techniques
Chapter 6 Market Breakdown by Technology
Microarrays
Description
Microfluidic Devices
Market Size and Forecast
PCR
Market Size and Forecast
In Situ Hybridization
Labeling Techniques
In Situ Hybridization Applications
Fiber Fish
Her2 Fish Testing
Market Size and Forecast
Others
Trend Toward Single-Cell Measurements
Market Size and Forecast
Chapter 7 Molecular Diagnostics by Application
Infectious Diseases
Market Size and Forecast
Oncology
Leukemias
Chronic Myeloid Leukemia
Genetic Marker of Chronic Myeloid Leukemia
Market Size and Forecast
Pre- and Post-Natal Screening
Carrier Screening
Prenatal Diagnostic Testing
Amniocentesis
Chorionic Villus Sampling
Genetic Counseling
Preimplantation Diagnosis
Newborn Screening
Market Size and Forecast
Identity and Paternity
Paternity Testing
Technology
Accreditation
Legal Issues
Veterinary Identity Testing
Market Size and Forecast
Others
Market Size and Forecast
Chapter 8 Market Breakdown by Region
Global Molecular Diagnostic Market by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Chapter 9 Regulations and Finance
Overview
Europe
U.S.
Japan
Insurance
Food and Drug Administration Guidelines
Internal Standards for DNA Diagnostics
Minimum Information about a Microarray
Experiment: MIAME 2.0
Microarray Quality Control Project
Clinical Laboratory Improvement Amendments
Personalized Medicines and Companion Diagnostics
FDA Guidelines for In Vitro Companion Diagnostics
Definition and Use of an IVD Companion Diagnostic Device
Review and Approval of IVD Companion Diagnostic Devices and Therapeutic Products
Novel Therapeutic Products
Approval of a Therapeutic Product without an Approved IVD Companion Diagnostic Device
General Policies
FDA Approved Companion Diagnostics
Nucleic Acid-Based Tests
Pharmacogenomics Research Network
Chapter 10 Patents
Chapter 11 Competitive Landscape
Overview
Chapter 12 Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
ALMAC GROUP
BECTON, DICKINSON AND CO.
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
CARDINAL HEALTH
DANAHER CORP.
ELITECH GROUP
GENERAL ELECTRIC
HOLOGIC INC.
ILLUMINA INC.
MYRIAD GENETICS
GRIFOLS (NOVARTIS MOLECULAR DIAGNOSTICS)
PHILIPS HEALTHCARE
QIAGEN N.V.
QUEST DIAGNOSTICS
ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.

List of Tables
Summary Table : Global Molecular Diagnostic Market, by Region, Through 2026
Table 1 : Global HIV Data, 2000-2020
Table 2 : Global Leading Causes of Disease, 2004 and 2030
Table 3 : National Institutes of Health Funding Estimates for Various Conditions and Diseases, 2014-2019
Table 4 : Global Molecular Diagnostic Market, by Technology, Through 2026
Table 5 : Global Molecular Diagnostic Market, by Application, Through 2026
Table 6 : Global Molecular Diagnostic Market, by Region, Through 2026
Table 7 : North American Molecular Diagnostic Market, by Technology, Through 2026
Table 8 : North American Molecular Diagnostic Market, by Application, Through 2026
Table 9 : North American Molecular Diagnostic Market, by Country, Through 2026
Table 10 : U.S. Estimated Number of New Cancer Cases, 2021
Table 11 : European Molecular Diagnostic Market, by Technology, Through 2026
Table 12 : European Molecular Diagnostic Market, by Application, Through 2026
Table 13 : European Molecular Diagnostic Market, by Country, Through 2026
Table 14 : Asia-Pacific Molecular Diagnostic Market, by Technology, Through 2026
Table 15 : Asia-Pacific Molecular Diagnostic Market, by Application, Through 2026
Table 16 : Asia-Pacific Molecular Diagnostic Market, by Country, Through 2026
Table 17 : Rest of the World Molecular Diagnostic Market, by Technology, Through 2026
Table 18 : Rest of the World Molecular Diagnostic Market, by Application, Through 2026
Table 19 : Class I and Class II Exempt Devices
Table 20 : Minimum Information About a Microarray Experiment: MIAME 2.0
Table 21 : Microarray Quality Control Project
Table 22 : U.S. Laboratories CLIA-Certified for Molecular Diagnostics and Number of Disease Tests
Table 23 : U.S. Genetic Testing Procedures, by Type, 2015
Table 24 : FDA-Approved In Vitro Companion Diagnostic Devices, June 1, 2017
Table 25 : Nucleic Acid-Based Tests Cleared or Approved by the Center for Devices and Radiological Health, June 1, 2017
Table 26 : Nucleic Acid-Based Tests Cleared or Approved by the Center for Devices and Radiological Health, June 1, 2017
Table 27 : Selected Molecular Diagnostics, 2020-2021
Table 28 : Global Molecular Diagnostic Market Shares, by Manufacturer, 2020
Table 29 : Abbott: Financials, 2016-2020
Table 30 : Abbott: Product Portfolio, by Business Segment
Table 31 : Abbott: Point of Care Diagnostic Products
Table 32 : Abbott: Recent Developments, October 2017-September 2021
Table 33 : Agilent Technologies Inc.: Product Portfolio
Table 34 : Almac Group: Product Portfolio
Table 35 : Becton, Dickinson and Company: Product Portfolio
Table 36 : bioMerieux S.A.: Product Portfolio
Table 37 : BioRad Laboratories: Product Portfolio
Table 38 : Cardinal Health Inc.: Product Portfolio
Table 39 : Danaher Corp.: Product Portfolio
Table 40 : ELITech Group: Product Portfolio
Table 41 : General Electric: Financial Performance, 2019 and 2020
Table 42 : General Electric Healthcare: Molecular Diagnostics Products
Table 43 : Hologic Inc.: Product Portfolio
Table 44 : Illumina Inc.: Product Portfolio
Table 45 : Myriad Genetics: Product Portfolio
Table 46 : Novartis Molecular Diagnostics: Product Portfolio
Table 47 : Philips Healthcare: Product Portfolio
Table 48 : Qiagen N.V.: Product Portfolio
Table 49 : Quest Diagnostics: Product Portfolio
Table 50 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 51 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 52 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 53 : F. Hoffmann-La Roche Ltd.: Recent Developments, June 2017-April 2020
Table 54 : Siemens Healthcare GmbH: Product Segments
Table 55 : Siemens Healthcare GmbH: Molecular Diagnostics Products
Table 56 : Siemens Healthcare GmbH: Financials, 2019
Table 57 : Siemens Healthcare GmbH: Key Developments
Table 58 : Thermo Fisher Scientific: Product Portfolio
Table 59 : Thermo Fisher Scientific: Key Developments, 2021

List of Figures
Summary Figure A : Global Molecular Diagnostic Market, by Region, 2019-2026
Summary Figure B : Global Molecular Diagnostic Market Shares, by Region, 2020
Figure 1 : Incidences of Diagnosed Infectious Disease, by Country, 2019
Figure 2 : Distribution of Malaria Cases, by Country, 2018
Figure 3 : Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
Figure 4 : Increased Incidence of Cancer, 2012 and 2030
Figure 5 : Global Distribution of Deaths from Chronic Diseases, 2018
Figure 6 : Flow of Funding for Disease Research, 2014-2018
Figure 7 : Global Funding in Tuberculosis Research and Development, by Institutions, 2019
Figure 8 : Rising Trends in Healthcare Spending, by Institution, 2015-2040
Figure 9 : Global Molecular Diagnostic Market Shares, by Technology, 2020
Figure 10 : Global Molecular Diagnostic Market, by Technology, 2019-2026
Figure 11 : Global Microarray Market, 2019-2026
Figure 12 : Global PCR Market, 2019-2026
Figure 13 : Global ISH Market, 2019-2026
Figure 14 : Global Others Market, 2019-2026
Figure 15 : Global Molecular Diagnostic Market Shares, by Application, 2020
Figure 16 : Global Molecular Diagnostic Market, by Application, 2019-2026
Figure 17 : Global Infectious Disease Market, 2019-2026
Figure 18 : Global Oncology Market, 2019-2026
Figure 19 : Global Pre- and Post-Natal Screening Market, 2019-2026
Figure 20 : Global Identity and Paternity Market, 2019-2026
Figure 21 : Global Others Market, 2019-2026
Figure 22 : Global Molecular Diagnostic Market Shares, by Region, 2020
Figure 23 : North American Molecular Diagnostic Market Shares, by Technology, 2020
Figure 24 : North American Molecular Diagnostic Market Shares, by Application, 2020
Figure 25 : North American Molecular Diagnostic Market Shares, by Country, 2020
Figure 26 : U.S. Molecular Diagnostic Market, 2019-2026
Figure 27 : Canadian Molecular Diagnostic Market, 2019-2026
Figure 28 : European Molecular Diagnostic Market Shares, by Technology, 2020
Figure 29 : European Molecular Diagnostic Market Shares, by Application, 2020
Figure 30 : European Molecular Diagnostic Market Shares, by Country, 2020
Figure 31 : German Molecular Diagnostic Market, 2019-2026
Figure 32 : U.K. Molecular Diagnostic Market, 2019-2026
Figure 33 : French Molecular Diagnostic Market, 2019-2026
Figure 34 : Italy New Disease Cases, 2020
Figure 35 : Italian Molecular Diagnostic Market, 2019-2026
Figure 36 : Spain Share of New Cases, 2020
Figure 37 : Spanish Molecular Diagnostic Market, 2019-2026
Figure 38 : Rest of European Molecular Diagnostic Market, 2019-2026
Figure 39 : Asia-Pacific Molecular Diagnostic Market Shares, by Technology, 2020
Figure 40 : Asia-Pacific Molecular Diagnostic Market Shares, by Application, 2020
Figure 41 : Asia-Pacific Molecular Diagnostic Market Shares, by Country, 2020
Figure 42 : China New Cancer Cases, 2020
Figure 43 : China New Cancer Cases Share, 2020
Figure 44 : Chinese Molecular Diagnostic Market, 2019-2026
Figure 45 : Japanese Molecular Diagnostic Market, 2019-2026
Figure 46 : Indian Molecular Diagnostic Market, 2019-2026
Figure 47 : Rest of Asia-Pacific Molecular Diagnostic Market, 2019-2026
Figure 48 : Africa New Cancer Cases, 2020
Figure 49 : Rest of the World Molecular Diagnostic Market Shares, by Technology, 2020
Figure 50 : Rest of the World Molecular Diagnostic Market Shares, by Application, 2020
Figure 51 : U.S. Process for Marketing a Medical Device
Figure 52 : Growth in Clinical Laboratory Sites and Disease Testing, 2012-2015
Figure 53 : Global Molecular Diagnostic Market Shares, by Manufacturer, 2020
Figure 54 : Abbott: Revenue Share, by Region or Country,
Figure 55 : Abbott: Revenue Share, by Business Segment
Figure 56 : Becton, Dickinson and Company: Annual Revenue, 2018-2020
Figure 57 : Becton, Dickinson and Company: Revenue Share, by Region, 2020
Figure 58 : Becton, Dickinson and Company: Revenue Share, by Business Segment, 2020
Figure 59 : Danaher Corp.: Annual Revenue, 2018-2020
Figure 60 : Danaher Corp.: Revenue Share, by Geography, 2020
Figure 61 : Danaher Corp.: Revenue Share, by Segment, 2020
Figure 62 : General Electric: Revenue Share, by Business Segment, 2020
Figure 63 : General Electric Healthcare: Revenue Share, by Region, 2020
Figure 64 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 65 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region or Country, 2019
Figure 66 : Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2019
Figure 67 : Siemens Healthcare GmbH: Revenue Share, by Region, 2019
Figure 68 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
Figure 69 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 70 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $5500.00
  • $6600.00
  • $7920.00
  • $9504.00
  • ADD TO BASKET
  • BUY NOW